Apathy in Dementia Methylphenidate Trial (ADMET)

NCT01117181 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Apathy
Alzheimer's Disease

Interventions

DRUG: Methylphenidate
DRUG: placebo
OTHER: Psychosocial intervention

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]